Bioentrepreneur
Publisher: Springer Nature · ISSN 1542-6572,1542-6572 · 25 articles
- Startups on the menu: Nascient
-
In vogue with venture
What types of life science enterprises are attracting venture capitalists today?
-
The Isis manifesto
Stan Crooke details the challenges in building a venture around an innovative platform and the implications for the industry going forward.
-
Commercializing a disruptive technology
Building any biotech business is hard, but building one based on a new, unproven technology or approach requires special care.
-
Granting you success
Non-dilutive funding from government programs can help startups move forward.
-
What mergers can do for you
With careful due diligence, help from financiers and a keen eye, even small companies can grow through mergers and acquisitions.
-
Safe and sound
How should you go about protecting the assets in your business?
-
For the records
Startup or not, your company needs to put in place a process for establishing and maintaining high-quality financial records.
-
Divining the path to a successful European exit
A gathering of biotech leaders in Sweden attempts to share candid opinions on the most successful strategies for building a biotech in Europe.
-
Streamlining your business for success
In the current fund-raising environment, focusing on rapid decision making, spreading risk across several assets and introducing innovative trial designs could pay dividends for biotech entrepreneurs.
-
Battling infringement
As more startups share competitive business information in their search for partners within big pharma or biotech, what legal protections are available if their intellectual property is infringed upon?
-
Around the block
A blocking patent can kill your business before it's off the ground.
-
Making the leap into entrepreneurship
Job security in big pharma is not what it once was. For those looking for a new challenge, a group of big company refugees recount their experience starting up a new life science venture.
-
Why you need a lawyer
What's involved in formally starting a biotech company?
-
Disclosing discoveries
Toiling away at the university, you've just made your once-in-a-lifetime discovery. Here's how to survive what comes next.
-
At ground level
The hardest—and perhaps loneliest—period of being an entrepreneur might be just after your company is founded.
-
Ask your doctor
When seeking a licensing partner for a product in development, market projections and strategies require substantiation. This can be provided through physician interviews.
-
Beyond venture capital
You don't always have to go to venture capitalists to raise funds. Proper planning and research can help you bring in millions through other avenues.
-
Avoiding capital punishment
In an industry with a lengthy product development timeline, capital efficiency is paramount. But successful capital-efficient strategies require a different approach to thinking, working and fundraising.
-
Selling out
Preferred stock preferences bite into an entrepreneur's returns. What can you do to put venture capitalists on a diet?
-
Seeking the biotech eBay
Internet exchanges suggest an easy route to sourcing and licensing technology, but can biotech intellectual property be packaged up and sold in this way?
-
Coming to terms
Before taking other people's money to finance your venture, it pays to fully educate yourself about the strings attached.
-
Backing your brand
Branding is one of the most important and powerful aspects of building a business, but it requires delicate maintenance to keep it working for you instead of against you.
-
Negotiation 2.0
Business negotiations can be tricky, but with the help of some specialized software the process can be streamlined.
-
The valuation high ground
Holding the valuation high ground allows a biotech company to get the most value from potential partners. Here is how to establish and defend financial valuation.